3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sezary Syndrome
3
Lymphoma, T-Cell, Peripheral
3
Leukemia-Lymphoma, Adult T-Cell
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Advanced/Metastatic Solid Tumors
1
Advanced Solid Tumors
1
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
mogamulizumab
×
Clear all
No trials found.